title: Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia.
abstract: Recent advances now permit resection of many pharyngeal tumors through the open mouth, an approach that can greatly reduce the morbidity of surgical exposure. These transoral techniques are being rapidly adopted by the surgical community and hold considerable promise. On November 6-7, 2011, the National Cancer Institute sponsored a Clinical Trials Planning Meeting to address how to further investigate the use of transoral surgery, both in the good prognosis human papillomavirus (HPV)-initiated oropharyngeal cancers, and in those with HPV-unrelated disease. The proceedings of this meeting are summarized.
authors.affiliation: Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA. adelstd@ccf.org
authors.forename: David J
authors.initials: DJ
authors.lastname: Adelstein
authors.forename: John A
authors.initials: JA
authors.lastname: Ridge
authors.forename: David M
authors.initials: DM
authors.lastname: Brizel
authors.forename: F Christopher
authors.initials: FC
authors.lastname: Holsinger
authors.forename: Bruce H
authors.initials: BH
authors.lastname: Haughey
authors.forename: Brian
authors.initials: B
authors.lastname: O'Sullivan
authors.forename: Eric M
authors.initials: EM
authors.lastname: Genden
authors.forename: Jonathan J
authors.initials: JJ
authors.lastname: Beitler
authors.forename: Gregory S
authors.initials: GS
authors.lastname: Weinstein
authors.forename: Harry
authors.initials: H
authors.lastname: Quon
authors.forename: Douglas B
authors.initials: DB
authors.lastname: Chepeha
authors.forename: Robert L
authors.initials: RL
authors.lastname: Ferris
authors.forename: Randal S
authors.initials: RS
authors.lastname: Weber
authors.forename: Benjamin
authors.initials: B
authors.lastname: Movsas
authors.forename: John
authors.initials: J
authors.lastname: Waldron
authors.forename: Val
authors.initials: V
authors.lastname: Lowe
authors.forename: Scott
authors.initials: S
authors.lastname: Ramsey
authors.forename: Judith
authors.initials: J
authors.lastname: Manola
authors.forename: Bevan
authors.initials: B
authors.lastname: Yueh
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Carey
authors.forename: Justin E
authors.initials: JE
authors.lastname: Bekelman
authors.forename: Andre A
authors.initials: AA
authors.lastname: Konski
authors.forename: Eric
authors.initials: E
authors.lastname: Moore
authors.forename: Arlene
authors.initials: A
authors.lastname: Forastiere
authors.forename: David E
authors.initials: DE
authors.lastname: Schuller
authors.forename: Jean
authors.initials: J
authors.lastname: Lynn
authors.forename: Claudio Dansky
authors.initials: CD
authors.lastname: Ullmann
mesh_terms: D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D015897:Comorbidity; D003226:Congresses as Topic; D003362:Cost-Benefit Analysis; D006258:Head and Neck Neoplasms / Q000191:economics / Q000453:epidemiology / Q000473:pathology / Q000628:therapy / Q000821:virology; D006801:Humans; D008866:Microsurgery; D009364:Neoplasm Recurrence, Local; D009959:Oropharyngeal Neoplasms / Q000473:pathology / Q000517:prevention & control / Q000601:surgery / Q000628:therapy; D030361:Papillomavirus Infections / Q000150:complications; D010610:Pharyngeal Neoplasms / Q000473:pathology / Q000517:prevention & control / Q000601:surgery* / Q000628:therapy; D011788:Quality of Life; D012107:Research Design; D012371:Robotics; D016896:Treatment Outcome